Phase Ib study of PF-05082566 in combination with pembrolizumab in patients with advanced solid tumors
Tolcher, Anthony W., Sznol, Mario, Hu-Lieskovan, Siwen, Papadopoulos, Kyriakos P., Patnaik, Amita, Rasco, Drew W., Di Gravio, Donna, Huang, Bo, Gambhire, Dhiraj, Chen, Ying, Pathan, Nuzhat, Wang, Kai, Schmidt, Emmett V., Chow, Laura Quan Man
Published in Journal of clinical oncology (20.05.2016)
Published in Journal of clinical oncology (20.05.2016)
Get full text
Journal Article
A phase I study of SAR566658, an anti CA6-antibody drug conjugate (ADC), in patients (Pts) with CA6-positive advanced solid tumors (STs)(NCT01156870)
Gomez-Roca, Carlos Alberto, Boni, Valentina, Moreno, Victor, Morris, John Charles, Delord, Jean-Pierre, Calvo, Emiliano, Papadopoulos, Kyriakos P., Rixe, Olivier, Cohen, Patrick, Tellier, Alexia, Ziti-Ljajic, Samira, Tolcher, Anthony W.
Published in Journal of clinical oncology (20.05.2016)
Published in Journal of clinical oncology (20.05.2016)
Get full text
Journal Article
Phase I Study of E7820, an Oral Inhibitor of Integrin α-2 Expression with Antiangiogenic Properties, in Patients with Advanced Malignancies
MITA, Monica, KELLY, Kevin R, GILES, Francis J, ROWINSKY, Eric K, TAKIMOTO, Chris, MITA, Alain, RICART, Alejandro D, ROMERO, Ofelia, TOLCHER, Anthony, HOOK, Laurel, OKEREKE, Chukwuemeka, KRIVELEVICH, Ilya, ROSSIGNOL, Daniel P
Published in Clinical cancer research (2011)
Published in Clinical cancer research (2011)
Get full text
Journal Article
Abstract CT003: Activity of the ERK1/2 inhibitor ulixertinib (BVD-523) in patients with BRAF and NRAS mutant melanoma
Sullivan, Ryan J., Janku, Filip, Li, Bob T., Wong, Deborah, Sosman, Jeffrey, Keedy, Vicki, Buchbinder, Elizabeth, Tolcher, Anthony, Varghese, Anna, Hyman, David M., Flaherty, Keith T., Ribas, Antoni, Carvajal, Richard, Wang-Gillam, Andrea, Kluger, Harriet, Patel, Manish, Langecker, Peter, Varterasian, Mary, Welsch, Dean, Infante, Jeffrey
Published in Cancer research (Chicago, Ill.) (01.07.2017)
Published in Cancer research (Chicago, Ill.) (01.07.2017)
Get full text
Journal Article
Continuous-dose regorafenib (REG) in hepatocellular carcinoma (HCC): Phase I safety and pharmacokinetic (PK) study
Finn, Richard S., Blumenschein, George R., Tolcher, Anthony W., Leong, Stephen, Boix, Oliver, Diefenbach, Konstanze
Published in Journal of clinical oncology (01.02.2013)
Published in Journal of clinical oncology (01.02.2013)
Get full text
Journal Article
Changes of lung tumour volume on CT - prediction of the reliability of assessments
Beaumont, Hubert, Souchet, Simon, Labatte, Jean Marc, Iannessi, Antoine, Tolcher, Anthony William
Published in Cancer imaging (31.10.2015)
Published in Cancer imaging (31.10.2015)
Get full text
Journal Article
First-in-class oral ERK1/2 inhibitor Ulixertinib (BVD-523) in patients with advanced solid tumors: Final results of a phase I dose escalation and expansion study
Li, Bob T., Janku, Filip, Patel, Manish R., Sullivan, Ryan J., Flaherty, Keith, Buchbinder, Elizabeth Iannotti, Lacouture, Mario E., Varghese, Anna M., Wong, Deborah Jean Lee, Sznol, Mario, Sosman, Jeffrey Alan, Keedy, Vicki Leigh, Wang-Gillam, Andrea, Ribas, Antoni, Tolcher, Anthony W., Patel, Sapna Pradyuman, Varterasian, Mary Laura, Welsch, Dean, Hyman, David Michael, Infante, Jeffrey R.
Published in Journal of clinical oncology (20.05.2017)
Published in Journal of clinical oncology (20.05.2017)
Get full text
Journal Article
Phase 1 safety of ICOS agonist antibody JTX-2011 alone and with nivolumab (nivo) in advanced solid tumors; predicted vs observed pharmacokinetics (PK) in ICONIC
Burris, Howard A., Callahan, Margaret K., Tolcher, Anthony W., Kummar, Shivaani, Falchook, Gerald Steven, Pachynski, Russell Kent, Tykodi, Scott S., Gibney, Geoffrey Thomas, Seiwert, Tanguy Y., Gainor, Justin F., LoRusso, Patricia, Hilbert, James, Apgar, Josh F, Hua, Fei, Burke, John M, Lazaro, Manny, Clancy, Myles, Ding, Baoyu, Trehu, Elizabeth G., Yap, Timothy Anthony
Published in Journal of clinical oncology (20.05.2017)
Published in Journal of clinical oncology (20.05.2017)
Get full text
Journal Article
Abstract CT227: Interim results of a phase 1b/2 study of ADG126 (a masked anti-CTLA-4 SAFEbody®) monotherapy and in combination with toripalimab (an anti-PD-1 antibody) in patients (pts) with advanced/metastatic solid tumors
Ariyapperuma, Mihitha, Park, John J., Khattak, Adnan, Richardson, Gary, Hamid, Anis, Morris, Michelle, Tolcher, Anthony W., Goh, Boon Cher, Lam, Justina, Chmielowski, Bartosz, She, Kristine, Zhang, Yanyan, Li, Ai, Zheng, Songmao, Liu, Guizhong, Zhu, Lvyu, Wang, Hongyan, Cui, Xiaoxing, Luo, Peter, Zha, Jiping
Published in Cancer research (Chicago, Ill.) (14.04.2023)
Published in Cancer research (Chicago, Ill.) (14.04.2023)
Get full text
Journal Article
Abstract CT034: GLIMMER-01: initial results from a phase 1 dose escalation trial of a first-in-class bi-sialidase (E-602) in solid tumors
Luke, Jason J., Johnson, Melissa, Tolcher, Anthony, Chen, Christopher T., Dai, Tong, Curti, Brendan D., El-Khoueiry, Anthony, Sznol, Mario, Henick, Brian S., Horak, Christine, Jayaraman, Pushpa, Cole, Christopher B., Wilson, Dawn, Cao, Lizhi, Peng, Li, Feltquate, David, Lathers, Deanne, Sharma, Manish R.
Published in Cancer research (Chicago, Ill.) (14.04.2023)
Published in Cancer research (Chicago, Ill.) (14.04.2023)
Get full text
Journal Article
ASN002: A Potent Dual SYK/JAK Inhibitor Currently in a Phase I/II Study Shows Strong Antitumor Activity in Preclinical Studies
Rao, Niranjan S., Reddy, Sanjeeva, Sandeep, Gupta, Damle, Nitin K, Aranapakam, Venkatesan M, Thompson, Scott, Smith, Roger, Plasse, Terry, Bristow, Penelope, Tolcher, Anthony, Papadopoulos, Kyriakos P, Patnaik, Amita, Rasco, Drew W
Published in Blood (03.12.2015)
Published in Blood (03.12.2015)
Get full text
Journal Article
Abstract 1223: Establishment, characterization and evaluation of a panel of head and neck patient-derived xenograft (PDX) models
Wick, Michael J., Vaught, Teresa, Gamez, Lizette, Diaz, Armando, Meade, Justin, Farley, Monica, Moriarty, Alyssa, Carlile, Jennifer, Tolcher, Anthony, Rasco, Drew, Patnaik, Amita, Newman, Richard, Papadopoulos, Kyriakos
Published in Cancer research (Chicago, Ill.) (01.10.2014)
Published in Cancer research (Chicago, Ill.) (01.10.2014)
Get full text
Journal Article
Abstract 2985: In vivo evaluation of regorafenib and liposomal-doxorubicin in a panel of low passage uterine START-PDX tumor models
Meade, Justin, Wick, Michael J., Vaught, Teresa, Gamez, Lizette, Chavez, Roger, Tolcher, Anthony, Rasco, Drew, Patnaik, Amita, White, Allan J., Papadopoulos, Kyriakos
Published in Cancer research (Chicago, Ill.) (01.10.2014)
Published in Cancer research (Chicago, Ill.) (01.10.2014)
Get full text
Journal Article
A phase 1 study of anti-TGF[beta] receptor type-II monoclonal antibody LY3022859 in patients with advanced solid tumors
Tolcher, Anthony W, Berlin, Jordan D, Cosaert, Jan, Kauh, John, Chan, Emily, Piha-paul, Sarina A, Amaya, Alex, Tang, Shande, Driscoll, Kyla, Kimbung, Richard, Kambhampati, S R; Prasad, Gueorguieva, Ivelina, Hong, David S
Published in Cancer chemotherapy and pharmacology (01.04.2017)
Published in Cancer chemotherapy and pharmacology (01.04.2017)
Get full text
Journal Article
Abstract CT307: Phase I, placebo-controlled, patient (pt)-blinded study to evaluate the effect of repeat oral dosing of the MEK inhibitor trametinib on cardiac repolarization in pts with solid tumors
Rasco, Drew, Patnaik, Amita, Tolcher, Anthony W., Papadopoulos, Kyriakos P., Beeram, Muralidhar, Chambers, Glenda, Werner, Theresa L., Bauman, John W., Scheuber, Anita, Cox, Donna, Zhou, YanYan, Hamid, Mohammed, Schramek, Daniel, Criscitiello, Peggy, Sharma, Sunil
Published in Cancer research (Chicago, Ill.) (01.08.2015)
Published in Cancer research (Chicago, Ill.) (01.08.2015)
Get full text
Journal Article
Abstract 1457: Genomic characterization of a PDX model of T-DM1-resistant HER2+ invasive ductal carcinoma using augmented exome sequencing
Helman, Elena, Wick, Michael J., Clark, Michael J., Gamez, Lizette, Boyle, Sean, Papadopoulos, Kyriakos P., Luo, Shujun, Tolcher, Anthony W., Sripakdeevong, Parin, Karbelashvili, Mirian, Church, Deanna, Chen, Richard, West, John
Published in Cancer research (Chicago, Ill.) (01.08.2015)
Published in Cancer research (Chicago, Ill.) (01.08.2015)
Get full text
Journal Article
Pharmacokinetics and safety of an oral ALK inhibitor, ASP3026, observed in a phase I dose escalation trial
Patnaik, Amita, LoRusso, Patricia, Ball, Howard A., Bahceci, Erkut, Yuen, Geoffrey, Papadopoulos, Kyriakos P., Kittaneh, Muaiad, Tolcher, Anthony W.
Published in Journal of clinical oncology (20.05.2013)
Published in Journal of clinical oncology (20.05.2013)
Get full text
Journal Article
Safety, activity, and pharmacokinetics of an oral anaplastic lymphoma kinase (ALK) inhibitor, ASP3026, observed in a “fast follower” phase 1 trial design
Maitland, Michael L., Ou, Sai-Hong Ignatius, Tolcher, Anthony W., LoRusso, Patricia, Bahceci, Erkut, Ball, Howard A, Park, Jung Wook, Yuen, Geoff, Pesco Koplowitz, Luana, Li, Tianhong
Published in Journal of clinical oncology (20.05.2014)
Published in Journal of clinical oncology (20.05.2014)
Get full text
Journal Article
Abstract A18: Establishment and characterization of serial patient derived xenograft models representing erlotinib sensitive/resistant non-small cell lung cancer
Wick, Michael J. J., Helman, Elena, Vaught, Teresa L., Farley, Monica, Gamez, Lizette, Moriarty, Alyssa, Ulmer, Scott, Tolcher, Anthony W., Rasco, Drew W., Clark, Michael, Patnaik, Amita, Papadopoulos, Kyriakos P.
Published in Molecular cancer therapeutics (01.12.2015)
Published in Molecular cancer therapeutics (01.12.2015)
Get full text
Journal Article
Abstract B118: A phase 1, open-label multiple dose escalation trial to determine safety and tolerability of once daily OPB-111077 in subjects with advanced cancer
Cote, Gregory, Papadopoulos, Kyriakos, Patnaik, Amita, Rascoe, Drew, Smith, Lon, Bullock, Andrea, Flaherty, Keith, Shapiro, Geoffrey, Berlin, Jordan, Monga, Manish, Habermann, Thomas, Witzig, Thomas, Lin, Chester, Tsai, Lin-Feng, Elekes, Agnes, Ohi, Naoto, Tatsumi, Kunihiko, Tolcher, Anthony
Published in Molecular cancer therapeutics (01.12.2015)
Published in Molecular cancer therapeutics (01.12.2015)
Get full text
Journal Article